Immune Checkpoint Inhibitors for Hepatobiliary Cancers

Review an on-demand Webcast from a live Webinar focused on current best practices and emerging strategies in using immune checkpoint inhibitors to treat patients with hepatocellular carcinoma and biliary tract cancers, and then download the slides and read an associated expert commentary.
R. Kate Kelley, MD
Amit G. Singal, MD, MS

Downloadable Slidesets

Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with hepatocellular carcinoma and biliary tract cancers.

R. Kate Kelley, MD Amit G. Singal, MD, MS Released: January 27, 2021

Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with hepatocellular carcinoma and biliary tract cancers.

R. Kate Kelley, MD Amit G. Singal, MD, MS Released: January 28, 2021

ClinicalThought

Read expert answers to audience questions from a live Webcast focused on current and emerging investigational uses of immune checkpoint inhibitors for HCC.

R. Kate Kelley, MD Amit G. Singal, MD, MS Released: February 11, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue